Left Atrial Enlargement: A Crucial Indicator for Identifying Atrial Fibrillation in Patients With Hypertension

CompletedOBSERVATIONAL
Enrollment

58,427

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

May 1, 2023

Conditions
Atrial FibrillationHypertension,EssentialLeft Atrial Dilatation
Interventions
DIAGNOSTIC_TEST

CHA2DS2-VASc score, C2HEST score, and left atrial diameter (LAD)

"CHA2DS2-VASc Score: Congestive heart failure (HF) \[1 point\], hypertension \[1 point\], age ≥ 75 years \[2 points\], diabetes \[1 point\], prior stroke or transient ischemic attack \[2 points\], vascular disease \[1 point\], age 65-74 years \[1 point\], and female gender\[1 point\].~C2HEST Score: Coronary artery disease or chronic obstructive pulmonary disease \[1 point each, 2 total points\]; hypertension \[1 point\]; elderly \[2 points for age ≥ 75 years\]; systolic HF \[2 points\]; and thyroid disease \[1 point for hyperthyroidism\]\[10\].~LAD: The LAD values of the enrolled patients were extracted by keyword search based on the results of echocardiography in the database."

Trial Locations (1)

400010

2ndChongqingMU, Chongqing

All Listed Sponsors
lead

The Second Affiliated Hospital of Chongqing Medical University

OTHER